Wang Xiangli, Li Yongchao, Liu Ting, Liu Chan, Lv Yeda, Liu Dongxu, Yuan Zhiming
Department of Anorectal and Burn Plastic Surgery, People's Hospital of Hengshui City, Hebei Province, Hengshui, 053000, Hebei, China.
Department of Burn and Plastic Surgery, People's Hospital of Hengshui City, Hebei Province, Hengshui, 053000, Hebei, China.
Aesthetic Plast Surg. 2025 Apr 30. doi: 10.1007/s00266-025-04882-0.
This study aimed to report the clinical effectiveness advantages of absorbable dressing (PELNAC) combined with physical antibacterial spray dressing in repairing secondary wounds from facial bumps.
Thirty-two patients comprising 20 in the experimental and 12 in the control group, respectively, were randomly selected. They had undergone excision or extended excision of facial bumps with wounds that could not be directly sutured. In the experimental group, after mass excision, the wounds were covered with PELNAC. In the control group, secondary wounds were repaired by skin grafts or skin flaps after mass excision or extended excision. The postoperative infection rate, healing rate, average healing time, scar formation, and sensory recovery were compared between the two groups.
The wound infection rate in the experimental group was significantly lower than in the control group (P<0.05); the surgery time for the experimental group was shortened by 1.5 h compared to the control group (P<0.05). Four weeks after surgery, all wounds in the experimental group had healed, with a significantly higher healing rate than in the control group (P<0.05). During follow-up, the scar scores in the experimental group were significantly lower than those in the control group (P<0.05).
The combination of PELNAC and physical antibacterial spray dressing in the repair of secondary wounds from facial bumps significantly reduced the incidence of wound infection, accelerated wound healing, reduced scar formation at the graft site, and minimized surgical trauma to the donor site.
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
本研究旨在报告可吸收敷料（聚乳酸羟基乙酸共聚物）联合物理抗菌喷雾敷料修复面部肿块继发创面的临床疗效优势。
随机选取32例患者，其中试验组20例，对照组12例。这些患者均接受了面部肿块切除或扩大切除，创面无法直接缝合。试验组在肿块切除后，创面覆盖聚乳酸羟基乙酸共聚物敷料。对照组在肿块切除或扩大切除后，采用植皮或皮瓣修复继发创面。比较两组术后感染率、愈合率、平均愈合时间、瘢痕形成及感觉恢复情况。
试验组创面感染率显著低于对照组（P<0.05）；试验组手术时间较对照组缩短1.5小时（P<0.05）。术后4周，试验组所有创面均愈合，愈合率显著高于对照组（P<0.05）。随访期间，试验组瘢痕评分显著低于对照组（P<0.05）。
聚乳酸羟基乙酸共聚物联合物理抗菌喷雾敷料修复面部肿块继发创面，显著降低了创面感染发生率，加速了创面愈合，减少了植皮部位瘢痕形成，并将供区手术创伤降至最低。
证据水平I：本刊要求作者为每篇文章指定证据水平。有关这些循证医学评级的完整描述，请参阅目录或作者在线指南www.springer.com/00266 。
